Business

Coloplast A/S - Q1 2025/26 Earnings Release - Invitation for conference call on 6 Feb 2026 at 11.00am CET

Friday, 6 February 2026 at 11:00-12:00am CETIn connection with the publication of Coloplast’s interim financial results for Q1 2025/26, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event. Colo

articleColoplast A/s Class BJanuary 26, 20261/company/coloplast-as-class-b/news/coloplast-as-q1-202526-earnings-release-invitation-for-conference-call-on-6-feb-2026-at-1100am-cet
Coloplast A/S - Q1 2025/26 Earnings Release - Invitation for conference call on 6 Feb 2026 at 11.00am CET

About this update from Coloplast A/s Class B

[{"type":"image","alt":"Coloplast A/S","displaySize":"","headline":null,"caption":"Coloplast A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":144,"url":"https://media.zenfs.com/en/globenewswire.com/e8ee650caffe7b5e9474eaac1733b4ef"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CnHAOjRIde9xT5OfHxnjSg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e8ee650caffe7b5e9474eaac1733b4ef","width":300,"height":144}},"lazy":false},{"type":"text","content":"Friday, 6 February 2026 at 11:00-12:00am CETIn connection with the publication of Coloplast’s interim financial results for Q1 2025/26, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available during and after the event.","length":497,"tagName":"p"},{"type":"text","content":"Coloplast will be represented by: Lars Rasmussen - Interim CEOAnders Lonning-Skovgaard - Executive Vice President, CFOKristine Husted Munk - Senior Director, Investor RelationsSimone Dyrby Helvind - Senior Manager, Investor Relations","length":247,"tagName":"p"},{"type":"text","content":"WebcastFor participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:Access the webcast here","length":179,"tagName":"p"},{"type":"text","content":"Dial-in detailsTo actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.Register for the conference call here","length":205,"tagName":"p"},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"text","content":"For more information, please contact:","length":37,"tagName":"p"},{"type":"text","content":"Kristine Husted Munk - Senior Director, Investor RelationsTel.: +45 4911 1800 / direct: +45 4911 3266. E-mail: [email protected]","length":136,"tagName":"p"},{"type":"text","content":"Simone Dyrby Helvind - Senior Manager, Investor RelationsTel.: +45 4911 1800 / direct: +45 4911 2981. E-mail: [email protected]","length":135,"tagName":"p"},{"t...

More updates from Coloplast A/s Class B

Coloplastconference callInvestor RelationsLars Rasmussenfinancial analystsKristine Husted Munk